Drug Trial Radar · NCT07252908
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Last checked: Nov 20, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
195
Actual
Start
Dec 22, 2025
Primary completion
Apr 28, 2026
Study completion May 7, 2026
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of TQC3721 inhalation powder in patients with moderate to severe Chronic obstructive pulmonary disease (COPD).
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
TQC3721 inhalation powderDrug
TQC3721 inhalation powder is target inhibitor.
Placebo for TQC3721 inhalation powderDrug
Placebo for TQC3721 inhalation powder.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of the maximum value of Forced Expiratory Volume in the first second (FEV1)Time frame: From baseline to four weeks after treatment
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chognqing, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
Guigang People's Hospital
Guigang, Guangxi, China
Zunyi Medical University Affiliated Hospital
Zunyi, Guizhou, China
Puyang Oilfield General Hospital
Puyang, Henan, China
Yichang Central People's Hospital
Yichang, Hubei, China
The People's Hospital of Liuyang
Changsha, Hunan, China
Xiangtan County People's Hospital
Xiangtan, Hunan, China
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Yixing People'S Hospital
Wuxi, Jiangsu, China
Jiujiang First People's Hospital
Jiujiang, Jiangxi, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Siping Central People's Hospital
Siping, Jilin, China
Heze Municipal Hospital
Heze, Shandong, China
Shanghai JiaoTong University of medicine Ruijin Hospital
Shanghai, Shanghai Municipality, China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Linfen People's Hospital
Linfen, Shanxi, China
Nuclear Industry 416 Hospital
Chengdou, Sichuan, China
Chengdu Fifth People's Hospital
Chengdu, Sichuan, China
Affiliated Hospital Of ChengDu University
Chengdu, Sichuan, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Suining Central Hospital
Suining, Sichuan, China
Yibin Second People's Hospital
Yibin, Sichuan, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
The Fourth Central Hospital of Tianjin
Tianjin, Tianjin Municipality, China
Taizhou central hospital (Taizhou university hospital)
Taizhou, Zhejiang, China
The 2th School of Medicine ,WMU/The 2th affiliated Hospital and Yuying Children's Hospital of WMU
Wenzhu, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.